Weed (BUDZ) EPS (Basic) (QoQ) (2011 - 2026)
Weed (BUDZ) EPS (Basic) (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.00 Bn | 43.04 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.30 Bn | 39.65 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.10 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.92 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.21 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.74% |
| Dec 31, 2025 | -2,770.11% |
| Sep 30, 2025 | 31.29% |
| Jun 30, 2025 | 75.57% |
| Mar 31, 2025 | -230.61% |
| Dec 31, 2024 | -41.79% |
| Sep 30, 2024 | 13.86% |
| Jun 30, 2024 | 36.25% |
| Mar 31, 2024 | 56.76% |
| Dec 31, 2023 | -153.61% |
| Sep 30, 2023 | 118.42% |
| Jun 30, 2023 | -1,923.58% |
| Mar 31, 2023 | -1.28% |
| Dec 31, 2022 | 93.53% |
| Sep 30, 2022 | 3.61% |
| Jun 30, 2022 | 7.67% |
| Mar 31, 2022 | -583.11% |
| Dec 31, 2021 | -159.33% |
| Sep 30, 2021 | 85.36% |
| Jun 30, 2021 | -23.89% |